awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33354786-606BBFED-16FE-4214-9D1E-AAF5112E2942
Q33354786-606BBFED-16FE-4214-9D1E-AAF5112E2942
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33354786-606BBFED-16FE-4214-9D1E-AAF5112E2942
Comparison of human B cell activation by TLR7 and TLR9 agonists.
P2860
Q33354786-606BBFED-16FE-4214-9D1E-AAF5112E2942
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33354786-606BBFED-16FE-4214-9D1E-AAF5112E2942
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3b724a07c64e223cb52ab09b81a0ecb7f81d5164
P2860
First in human phase I trial of 852A, a novel systemic toll-like receptor 7 agonist, to activate innate immune responses in patients with advanced cancer.